PMC9082156_01
Time course of OCT images for wet AMD in the right eye. a OCT image for wet AMD in the right eye before first intravitreal brolucizumab injection. b OCT image for improved wet AMD in the right eye at 1 month after first intravitreal brolucizumab injection. c OCT image for recurred wet AMD in the right eye 2 months after first intravitreal brolucizumab injection. d OCT image for wet AMD in the right eye 1 month after second intravitreal brolucizumab injection. OCT, optical coherence tomography.
cop-0013-0166-g01.jpg
PMC9082156_01_cop-0013-0166-g01.jpg
F1
Fundus photography and optical coherence tomography revealed wet AMD in the right eye (shown in Fig. 1).
Fundus photography image of choroidal effusion in the right eye at 3 days after intravitreal brolucizumab injection.
cop-0013-0166-g02.jpg
PMC9082156_01_cop-0013-0166-g02.jpg
F2
Three days after the second injection, on fundus examination, we observed choroidal effusion in the right eye (shown in Fig. 2).
Fundus photography image of worsened choroidal effusion in the right eye at 5 days after intravitreal brolucizumab injection.
cop-0013-0166-g03.jpg
PMC9082156_01_cop-0013-0166-g03.jpg
F3
There were no changes in the anterior chamber depth. Two days after the treatment, the choroidal effusion worsened (shown in Fig. 3).
Fundus photography image of resolved choroidal effusion in the right eye at 12 days after intravitreal brolucizumab injection.
cop-0013-0166-g04.jpg
PMC9082156_01_cop-0013-0166-g04.jpg
F4
One week after the last visit, on fundus examination, choroidal effusion in the right eye resolved without additional treatment (shown in Fig. 4).